In vitro enhancement of antitumor activity of a water-soluble duocarmycin derivative, KW-2189, by caffeine-mediated DNA-repair inhibition in human lung cancer cells

Japanese Journal of Cancer Research

Volumn 88, Issue 11, 1997, Pages 1033-1037

  Ogasawara, Hayato ^a   Nishio, Kazuto ^a   Ishida, Tomoyuki ^a   Arioka, Hitoshi ^a   Fukuoka, Kazuya ^a   Saijo, Nagahiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

DNA strand breaks; Duocarmycin; Excision repair; KW 2189; UV irradiation

Indexed keywords

ANTINEOPLASTIC AGENT; APHIDICOLIN; CAFFEINE; DNA; DU 86; DUOCARMYCIN B2; PIBROZELESIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA REPAIR; DRUG CYTOTOXICITY; DRUG POTENTIATION; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL;

EID: 0031449479     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00326.x     Document Type: Article

References (15)

1. Gomi, K., Kobayashi, E., Miyoshi, K., Ashizawa, T., Okamoto, A., Ogawa, T., Katsumata, S., Mihara, A., Okabe, M. and Hirata, T. Anticellular and antitumor activity of duocarmycins, novel antitumor antibiotics. Jpn. J. Cancer Res., 83, 113-120 (1992).
2. Kobayashi, E., Okamoto, A., Asada, M., Okabe, M., Nagamura, S., Asai, A., Saito, H., Gomi, K. and Hirata, T. Characteristics of antitumor activity of KW-2189, a novel water-soluble derivative of duocarmycin, against murine and human tumors. Cancer Res., 54, 2404-2410 (1994).
3. Ogasawara, H., Nishio, K., Takeda, Y., Ohmori, T., Kubota, N., Funayama, Y., Ohira, T., Kuraishi, Y., Isogai, Y. and Saijo, N. A novel antitumor antibiotic, KW-2189 is activated by carboxyl esterase and induces DNA strand breaks in human small cell lung cancer cells. Jpn. J. Cancer Res., 85, 418-425 (1994).
4. Ogasawara, H., Nishio, K., Kanzawa, F., Lee, Y.-S., Funayama, Y., Ohira, T., Kuraishi, Y., Isogai, Y. and Saijo, N. Intracellular carboxyl esterase activity is a determinant of cellular sensitivity to the antineoplastic agent KW-2189 in cell lines resistant to cisplatin and CPT-11. Jpn. J. Cancer Res., 86, 124-129 (1995).
5. Boger, D. L., Ishizaki, T. and Zarrinmayeh, H. Synthesis and preliminary evaluation of agents incorporating the pharmacophore of the duocarmycin/pyrindamycin alkylation subunit: identification of the CC-1065/duocarmycin common pharmacophore. J. Org. Chem., 55, 4499-4502 (1990).
6. Szymkowski, D. E., Yarema, K., Essigmann, J. M., Lippard, S. J. and Wood, R. D. An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts. Proc. Natl. Acad. Sci. USA, 89, 10772-10776 (1992).
7. Nishikawa, K., Rosenblum, M. G., Newman, R. A., Pandita, T. K., Hittelman, W. N. and Donato, N. J. Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor. Cancer Res., 52, 4758-4765 (1992).
8. Tang, M. S., Lee, C. S., Doisy, R., Ross, L., Needham-VanDevanter, D. R. and Hurley, L. H. Recognition and repair of the CC-1065-(N3-adenine)-DNA adduct by the UVRABC nucleases. Biochemistry, 27, 893-901 (1988).
9. Tang, M. S., Qian, M. and Pao, A. Formation and repair of antitumor antibiotic CC-1065-induced DNA adducts in the adenine phosphoribosyltransferase and amplified dihydrofolate reductase genes of Chinese hamster ovary cells. Biochemistry, 33, 2726-2732 (1994).
10. Kasahara, K., Fujiwara, Y., Nishio, K., Ohmori, T., Sugimoto, Y., Komiya, K., Matsuda, T. and Saijo, N. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res., 51, 3237-3242 (1991).
11. Sims, J. L., Sikorski, G. W., Catino, D. M., Berger, S. J. and Berger, N. A. Poly(adenosinediphosphoribose) polymerase inhibitors stimulate unscheduled deoxyribonucleic acid synthesis in normal human lymphocytes. Biochemistry, 21, 1813-1821 (1982).
12. Jacobson, M. K., Twehous, D. and Hurley, L. H. Depletion of nicotinamide adenine dinucleotide in normal and xeroderma pigmentosum fibroblast cells by the antitumor drug CC-1065. Biochemistry, 25, 5929-5932 (1986).
13. Tsuchiya, H., Tomita, K., Yasutake, H., Ueda, Y., Tanaka, M. and Sasaki, T. Growth inhibition and differentiation of murine melanoma B16-BL6 cells caused by the combination of cisplatin and caffeine. Jpn. J. Cancer Res., 80, 1246-1251 (1989).
14. Tomita, K. and Tsuchiya, H. Caffeine enhancement of the effect of anticancer agents on human sarcoma cells. Jpn. J. Cancer Res., 80, 83-88 (1989).
15. Yasutake, H., Tsuchiya, H., Tomita, K., Matsunaga, T., Nikaido, O. and Mori, T. Inhibitory effect of caffeine on potentially lethal damage repair in cisplatin-treated human osteosarcoma cells. Anticancer Res., 15, 831-837 (1995).